Embecta Corp. cash flow statement
In fiscal 2025, Embecta Corp.'s operations generated $192m of cash; it spent $9.3m on capital projects, leaving free cash flow of $182m. It returned $35.0m in dividends.
Cash flow statement
| Fiscal year | 2020Sept 2020 | 2021Sept 2021 | 2022Sept 2022 | 2023Sept 2023 | 2024Sept 2024 | 2025Sept 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operations | 499 | 456 | 412 | 68 | 36 | 192 | 174 |
| Depreciation and amortisation | 38 | 38 | 32 | 33 | 36 | 41 | 44 |
| Stock-based pay | 13 | 13 | 19 | 22 | 26 | 32 | 25 |
| Capital spending | 42 | 37 | 24 | 27 | 16 | 9 | 10 |
| Free cash flow | 457 | 420 | 389 | 41 | 20 | 182 | 165 |
| Free cash flow after stock pay | 444 | 407 | 370 | 20 | −6 | 151 | 139 |
| Dividends paid | 0 | 0 | 9 | 34 | 35 | 35 | 27 |
| Quarter | 2024 Q4Sept 2024 | 2025 Q1Dec 2024 | 2025 Q2Mar 2025 | 2025 Q3Jun 2025 | 2025 Q4Sept 2025 | 2026 Q1Dec 2025 | 2026 Q2Mar 2026 | 2026 Q3Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 27 | −5 | 32 | 81 | 84 | 17 | 31 | 42 |
| Depreciation and amortisation | 10 | 9 | 9 | 9 | 13 | 10 | 10 | 11 |
| Stock-based pay | 6 | 9 | 7 | 6 | 10 | 6 | 6 | 4 |
| Capital spending | 0 | 2 | 0 | 0 | 7 | 1 | 1 | 1 |
| Free cash flow | 27 | −7 | 32 | 81 | 77 | 17 | 31 | 41 |
| Free cash flow after stock pay | 20 | −16 | 24 | 75 | 67 | 11 | 25 | 37 |
Compare with peers
- UFP Technologies Inc cash flow
- ICU Medical Inc cash flow
- Organogenesis Holdings Inc. cash flow
- Envista Holdings Corp cash flow
- West Pharmaceutical Services cash flow
Head to head: EMBC vs UFPTEMBC vs ICUIEMBC vs ORGO
More: Health Care Supplies stocks compared, Health Care sector, rankings of US companies